1
/
of
0
FDA Drug Approval, N018845, METRONIDAZOLE
FDA Drug Approval, N018845, METRONIDAZOLE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 018845
Company: CHARTWELL MOLECULES
Drug Name: METRONIDAZOLE
Active Ingredients: METRONIDAZOLE
Strength: 250MG
Dosage Form/Route: TABLET;ORAL
Action Date: 08/18/1983
Marketing Status: Discontinued
Submission Classification:
Company: CHARTWELL MOLECULES
Drug Name: METRONIDAZOLE
Active Ingredients: METRONIDAZOLE
Strength: 250MG
Dosage Form/Route: TABLET;ORAL
Action Date: 08/18/1983
Marketing Status: Discontinued
Submission Classification:
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details